摩拉治疗仪治疗儿童过敏性结膜炎的临床分析

Clinical analysis of MORA therapeutic instrument in the treatment of allergic conjunctivitis children

摘要: 目的探讨德国MORA-super生物共振诊断治疗仪（以下简称摩拉治疗仪）对儿童过敏性结膜炎的临床疗效和安全性。方法将120例患有过敏性结膜炎的儿童进行分组，实验组和对照组各60例。实验组给予摩拉治疗仪治疗, 对照组给予0.5%富马酸依美斯汀滴眼液治疗, 对2组治疗结果进行评价。结果实验组与对照组总有效率分别为95.0%和83.3%，2组间差异有统计学意义（P＜0.05）。2组治疗后与治疗前相比，症状和体征均有改善。结论摩拉治疗仪对儿童过敏性结膜炎有较好的临床治疗效果，值得眼科推广应用。

Abstract: ObjectiveTo investigate the clinical efficacy and safety of German MORA-super diagnostic and therapeutic instrument for biological resonance in children with allergic conjunctivitis. MethodsA total of 120 children with allergic conjunctivitis were divided into an experiment group and a control group (n=60). The experiment group received MORA treatment, while the control group was given 0.5% emedastine difumarate eye drops. Then, the efficacy of the experiment group was evaluated. ResultsThe total effective rate was 95.0% for the experiment group which was statistical different from 83.3% for the control (P＜0.05). ConclusionsThe MORA therapeutic instrument is effective to treat allergic conjunctivitis in children.